beta
Trial Radar IA
Posso aiutarti a capire le condizioni di salute, i trattamenti o a trovare studi clinici vicini.
Il nostro strumento di ricerca supporta solo l'inglese. Per la ricerca e la discussione in altre lingue, usa Trial Radar IA sopra o seleziona i filtri per condizione medica e luogo (qui sotto).
159 risultati trovati
Primi 50 visualizzati
 
Stato (Predefinito)
Non Ancora in Arruolamento, In Arruolamento, Attivo, Non in Arruolamento
×
 
Intervento
GLP-1, GLP-1 receptor agonist
×
 
Titolo dello studio
Stato
Impact GLP-1 Agonists Following Bariatric NCT06132477
In arruolamento
GLP-1 RA on Liver OMICS in MASLD NCT06982378
Non ancora in arruolamento
Impact of GLP-1 Receptor Agonists on Patients With IPMN (IPMN-GLP1RA) NCT07014709
Non ancora in arruolamento
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy NCT07175805
Non ancora in arruolamento
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy NCT06903923
In arruolamento
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528
Non ancora in arruolamento
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery (Maigrir_OT) NCT06278285
In arruolamento
GLP1 Analogues and the Risk of Osteoarthritis NCT07360457
Non ancora in arruolamento
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists NCT07207148
In arruolamento
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD) NCT05390892
In arruolamento
Combination Therapy for Alcohol Use Disorder NCT07249554
Non ancora in arruolamento
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity (BETTER-GLP1) NCT07042672
In arruolamento
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Attivo, non in arruolamento
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM NCT06256419
In arruolamento
Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia NCT06654219
In arruolamento
Semaglutide and Preoperative Residual Gastric Volumes NCT06263595
In arruolamento
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs (ICDDTKZ26) NCT07303556
Attivo, non in arruolamento
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists NCT07224880
In arruolamento
Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance (LEAN-PRO GLP-1) NCT07495904
In arruolamento
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality NCT07127354
In arruolamento
Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists NCT07221461
Non ancora in arruolamento
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes (GLOW) NCT07428746
Non ancora in arruolamento
Comparison of Body Composition Changes With Weight Loss Interventions (REFORM) NCT07115069
In arruolamento
Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS NCT06889454
In arruolamento
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users (aGLP1-GUS) NCT06987669
Non ancora in arruolamento
Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery (GEM-GLP1RA) NCT07100691
Non ancora in arruolamento
Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients (GLP1-TASTE) NCT07229170
Non ancora in arruolamento
Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying (GLP-1) NCT06659159
Non ancora in arruolamento
Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist NCT06666049
In arruolamento
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (COMO-1) NCT06867718
Attivo, non in arruolamento
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse NCT07419854
In arruolamento
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS) NCT07169136
In arruolamento
Stanford Pediatric Healthy Weight Index NCT07316816
In arruolamento
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes (DECLARED-CT) NCT06715514
In arruolamento
POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS (GA22) NCT07019519
In arruolamento
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness NCT06487832
In arruolamento
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk (SIPPA-QH_HHC-2) NCT07032311
Non ancora in arruolamento
Comparative Effectiveness of Empagliflozin in the US NCT03363464
Attivo, non in arruolamento
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia NCT07107334
In arruolamento
Strength Training Response of Muscle in GLP-1 Users (STRONG-GLP) NCT07104539
In arruolamento
Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity NCT06775093
Non ancora in arruolamento
A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults (SOLUTION-Pilot) NCT07364175
In arruolamento
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery (GLORIOUS) NCT02673931
Attivo, non in arruolamento
A Study of a Weight Loss Intervention in People With Endometrial Cancer NCT06751589
In arruolamento
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment (PROBIO-GLP1) NCT07213323
Non ancora in arruolamento
Test dell'efficacia, della sicurezza e della PK di 20E in pazienti con obesità che iniziano il trattamento con l'agonista del GLP-1 semaglutide per la perdita di peso. (OBA) NCT07411378
Non ancora in arruolamento
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500
In arruolamento
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents NCT07307235
Non ancora in arruolamento
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes NCT05119179
In arruolamento
A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects NCT07327281
In arruolamento